TRIB TRINITY BIOTECH PLC

Nasdaq trinitybiotech.com


$ 0.99 $ -0.01 (-0.99 %)    

Monday, 03-Nov-2025 10:29:31 EST
QQQ $ 630.70 $ -4.45 (-0.7 %)
DIA $ 471.94 $ -4.20 (-0.88 %)
SPY $ 680.99 $ -4.65 (-0.68 %)
TLT $ 89.60 $ -0.06 (-0.06 %)
GLD $ 369.07 $ 0.21 (0.06 %)
$ 1
$ 1.00
$ 0.99 x 250
$ 1.01 x 100
$ 0.99 - $ 1.00
$ 0.88 - $ 17.20
39,719
na
17.96M
$ 1.30
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 trinity-biotech-regains-nasdaq-compliance

Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and dia...

 trinity-biotech-announces-clinical-trial-results-demonstrating-technical-breakthrough-and-de-risking-commercial-pathway-for-its-next-gen-continuous-glucose-monitoring-technology-called-cgm

Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes managemen...

 mhra-says-received-reports-describing-positive-bias-in-hba1c-results-delivered-by-trinity-biotech-premier-hb9210-hba1c-analyser-says-positive-bias-in-hba1c-results-resulted-in-patients-being-incorrectly-diagnosed-as-pre-diabetic-or-diabetic-trinity-biotech-committed-to-updating-intended-use-statement-in-the-instructions-for-use

https://www.gov.uk/drug-device-alerts/trinity-biotech-premier-hb9210-hba1c-analyser-risk-of-positive-bias-and-updates-to-instru...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION